1. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
2. Sanofi Genzyme . Dupixent 300 mg solution for injection in pre-filled syringe. Summary of product characteristics, GB. February 2024.
3. Biologics for COPD - finally here;Agusti;N Engl J Med,2023
4. National Institute for Health and Care Excellence . Dupilumab for treating moderate to severe chronic obstructive pulmonary disease ID6235 [online]. Available: https://www.nice.org.uk/guidance/indevelopment/gid-ta11246 [Accessed 22 May 2024].